Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus R Meyer

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
Toxicology Letters|December 27, 2017
Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approachAchim T Caspar, Markus R Meyer, Hans H Maurer
Drug Testing and Analysis|July 17, 2018
Blood plasma level determination using an automated LC-MS<sup>n</sup> screening system and electronically stored calibrations exemplified for 22 drugs and two active metabolites often requested in emergency toxicologyAchim T Caspar, Markus R Meyer, Hans H Maurer
Biochemical Pharmacology|May 12, 2009
Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2011
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approachAndrea E Schwaninger, Markus R Meyer, Hans H Maurer
Bioanalysis|November 11, 2014
Current position of high-resolution MS for drug quantification in clinical & forensic toxicologyMarkus R Meyer, Andreas G Helfer, Hans H Maurer
Analytical and Bioanalytical Chemistry|December 5, 2014
Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniquesJessica Welter, Pierce Kavanagh, Markus R Meyer, et al.
Analytical and Bioanalytical Chemistry|April 14, 2016
Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposesMarkus R Meyer, Madeleine Pettersson Bergstrand, Anders Helander, et al.
Toxicology Letters|August 8, 2017
New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urineLilian H J Richter, Hans H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|January 23, 2014
Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometryMarkus R Meyer, Carina Lindauer, Jessica Welter, et al.
Journal of Analytical Toxicology|July 30, 2019
Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive SubstancesSascha K Manier, Sophia Niedermeier, Jan Schäper, et al.
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
Toxicology Letters|December 27, 2017
Human cytochrome P450 kinetic studies on six N-2-methoxybenzyl (NBOMe)-derived new psychoactive substances using the substrate depletion approachAchim T Caspar, Markus R Meyer, Hans H Maurer
Drug Testing and Analysis|July 17, 2018
Blood plasma level determination using an automated LC-MS<sup>n</sup> screening system and electronically stored calibrations exemplified for 22 drugs and two active metabolites often requested in emergency toxicologyAchim T Caspar, Markus R Meyer, Hans H Maurer
Biochemical Pharmacology|May 12, 2009
Stereoselective differences in the cytochrome P450-dependent dealkylation and demethylenation of N-methyl-benzodioxolyl-butanamine (MBDB, Eden) enantiomersMarkus R Meyer, Frank T Peters, Hans H Maurer
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2011
Investigation on the enantioselectivity of the sulfation of the methylenedioxymethamphetamine metabolites 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxymethamphetamine using the substrate-depletion approachAndrea E Schwaninger, Markus R Meyer, Hans H Maurer
Bioanalysis|November 11, 2014
Current position of high-resolution MS for drug quantification in clinical & forensic toxicologyMarkus R Meyer, Andreas G Helfer, Hans H Maurer
Analytical and Bioanalytical Chemistry|December 5, 2014
Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MS(n) techniquesJessica Welter, Pierce Kavanagh, Markus R Meyer, et al.
Analytical and Bioanalytical Chemistry|April 14, 2016
Identification of main human urinary metabolites of the designer nitrobenzodiazepines clonazolam, meclonazepam, and nifoxipam by nano-liquid chromatography-high-resolution mass spectrometry for drug testing purposesMarkus R Meyer, Madeleine Pettersson Bergstrand, Anders Helander, et al.
Toxicology Letters|August 8, 2017
New psychoactive substances: Studies on the metabolism of XLR-11, AB-PINACA, FUB-PB-22, 4-methoxy-α-PVP, 25-I-NBOMe, and meclonazepam using human liver preparations in comparison to primary human hepatocytes, and human urineLilian H J Richter, Hans H Maurer, Markus R Meyer
Analytical and Bioanalytical Chemistry|January 23, 2014
Dimethocaine, a synthetic cocaine analogue: studies on its in-vivo metabolism and its detectability in urine by means of a rat model and liquid chromatography-linear ion-trap (high-resolution) mass spectrometryMarkus R Meyer, Carina Lindauer, Jessica Welter, et al.
Journal of Analytical Toxicology|July 30, 2019
Use of UPLC-HRMS/MS for In Vitro and In Vivo Metabolite Identification of Three Methylphenidate-derived New Psychoactive SubstancesSascha K Manier, Sophia Niedermeier, Jan Schäper, et al.
Pageof 27